Juan P. Alderuccio, MD
2 clinical trials · Sponsor
◉ Watch Juan P. Alderuccio, MD
| Record | Firm | Date |
|---|---|---|
| Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma (NCT06730542) | Juan P. Alderuccio, MD | 2025-04-17 |
| Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma (NCT04998669) | Juan P. Alderuccio, MD | 2022-02-11 |
Track Juan P. Alderuccio, MD automatically
Every clearance here is in the API, with alerts when new ones post.